Aortic Valve Disease
1 competing product in clinical development for Aortic Valve Disease.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Apixaban 5 MG + Apixaban 2.5 MG + Warfarin | Artivion | Phase 3 | Terminated | 72 |
1 competing product in clinical development for Aortic Valve Disease.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Apixaban 5 MG + Apixaban 2.5 MG + Warfarin | Artivion | Phase 3 | Terminated | 72 |